Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Renal Biomarkers Market Growth in 2025?

The kidney marker industry has seen substantial growth recently. The market’s value is anticipated to rise from $1.28 billion in 2024 to $1.38 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period resulted from factors such as a rise in kidney disease cases, enhancements in medical diagnostic methods, an aging population, increasing awareness about early disease identification, acceptance of point-of-care testing, and a surge in chronic illnesses.

What Is the Forecast for the Renal Biomarkers Market Size Through 2029?

The market size for renal biomarkers is projected to experience significant escalation in the coming years, reaching $1.91 billion by 2029 with a compound annual growth rate of 8.5%. Factors contributing to this expected growth during the forecast period include the prevalence of personalized and targeted therapies, incorporation of biomarkers testing in regular clinical procedures, burgeoning markets in Asia and Latin America, non-evasive techniques for biomarker testing, and constant monitoring through wearable technology. Major trends anticipated during this period comprise comprehensive disease profiling using multiplex biomarker panels, the utilization of AI and machine learning in discovering biomarkers, companion diagnostics based on biomarkers, Point-of-care (POC) biomarker testing in home healthcare environments, and the use of biomarkers for early detection and prevention.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp

What are the Key Market Players in Renal Biomarkers Market and How They’re Evolving?

Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.

What Are the Primary Growth Drivers in the Renal Biomarkers Market?

The increase in older adults and children suffering from kidney conditions is anticipated to drive the renal biomarkers market’s expansion. Elderly renal patients refer to individuals over the age of 70 who are suffering from severe chronic kidney disease (CKD). On the other hand, paediatric renal patients are those typically identified with kidney disorders during their childhood or early adulthood. Renal biomarkers are essential for assessing the intensity of kidney damage in these demographic groups. For instance, as per the Australian Institute of Health and Welfare, a government agency based in Australia, the mortality rates due to chronic kidney disease (CKD) surged by 4.2% in 2021 and 6.2% in 2022. Therefore, the increasing amount of older and younger people suffering from kidney conditions is fuelling the expansion of the renal biomarkers industry.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7711&type=smp

What Are the Leading Segments in the Global Renal Biomarkers Industry?

The renal biomarkers market covered in this report is segmented –

1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types

2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)

3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare

4) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Functional Biomarker: Creatinine, Urea, Cystatin C, Bicarbonate

2) By Up Regulated Protein: Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Interleukin-18 (IL-18)

3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers, Acute Kidney Injury Biomarkers, Chronic Kidney Disease Biomarkers

What Are the Key Market Trends in the Renal Biomarkers Industry?

The emergence of technological advancements has become a significant trend in the renal biomarkers market. The major market players in the renal biomarkers segment are concentrating on innovating technologies to maintain their dominance in the market. For instance, in March 2022, Nipro Medical Corporation, a medical equipment manufacturer based in the US, introduced SURDIAL DX. This brand-new hemodialysis system showcases high-tech features aimed at improving patient safety, comfort, and efficiency. The device comes with a modern design with an emphasis on automated processes, ergonomic aesthetics, and commitment to elevating the overall dialysis treatment experience.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

What Is the Regional Outlook for the Renal Biomarkers Market?

North America was the largest region in the renal biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7711

This Report Delivers Insight On:

1. How big is the renal biomarkers market, and how is it changing globally?

2. Who are the major companies in the renal biomarkers market, and how are they performing?

3. What are the key opportunities and risks in the renal biomarkers market right now?

4. Which products or customer segments are growing the most in the renal biomarkers market?

5. What factors are helping or slowing down the growth of the renal biomarkers market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model